Chapter 10 RNA Aptamers to Translational Components

Progress in Molecular Biology and Translational Science

Volumn 90, Issue C, 2009, Pages 369-395

  Nakamura, Yoshikazu ^a   Endo, Kei ^a   Adachi, Hironori ^a   Ishiguro, Akira ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

aptamer therapeutics; human initiation factors; natural aptamer; RNA aptamer; RNA plasticity; SELEX

Indexed keywords

APTAMER; INITIATION FACTOR;

CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS; REVIEW;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; PEPTIDE INITIATION FACTORS; PROTEIN BIOSYNTHESIS;

EID: 77957027681     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-1173(09)90010-2     Document Type: Review

References (154)

1. Hershey J.W.B., and Merrick W.C. Pathway and mechanism of initiation of protein synthesis. In: Sonenberg N., Hershey J.W.B., and Mathews M.B. (Eds). Translational control of gene expression (2000), Cold Spring Harbour Laboratory Press, Cold Spring Harbour, New York 33-88
2. Gingras A.-C., Raught B., and Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68 (1999) 913-963
3. Yoder-Hill J., Pause A., Sonenberg N., and Merrick W.C. The p46 subunit of eukaryotic initiation factor (eIFs)-4F exchanges with eIF-4A. J Biol Chem 268 (1993) 5566-5573
4. Pause A., Méthot N., Svitkin Y., Merrick W.C., and Sonenberg N. Dominant negative mutants of mammalian translation initiation factor eIF-4A define a critical role for eIF-4F in cap-dependent and cap-independent initiation of translation. EMBO J 13 (1994) 1205-1215
5. Rozen F., Every I., Meerovitch K., Dever T.E., Merrick W.C., and Sonenberg N. Bidirectional RNA helicase activity of eukaryotic translation initiation factors 4A and 4F. Mol Cell Biol 10 (1990) 1134-1144
6. Sonenberg N. mRNA 5′ cap-binding protein eIF4E and control of cell growth. In: Hershey J.W.B., Mathew M.B., and Sonenberg N. (Eds). Translational control (1996), Cold Spring Harbour Laboratory Press, Cold Spring Harbour, New York 245-269
7. Nielsen P.J., and Trachsel H. The mouse protein synthesis initiation factor 4A gene family includes two related functional genes which are differentially expressed. EMBO J 7 (1988) 2097-2105
8. Li Q., Imataka H., Morino S., Rogers G.W., Richter-Cook N.J., Merrick W.C., et al. Eukaryotic translation initiation factor 4AIII (eIF4AIII) is functionally distinct from eIF4AI and eIF4AII. Mol Cell Biol 19 (1999) 7336-7346
9. De Benedetti A., and Rhoads R.E. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc Natl Acad Sci USA 87 (1990) 8212-8216
10. De Benedetti A., Joshi B., Graff J.R., and Zimmer S.G. CHO cells transformed by the translation factor eIF4E display increased c-myc expression but require overexpression of Max for tumorigenecity. Mol Cell Differ 2 (1994) 347-371
11. Lazaris-Karatzas A., Montana K.S., and Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 345 (1990) 544-547
12. Kerekatte V., Smiley K., Hu B., Smith A., Gilder F., and De Benedetti A. The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas. Int J Cancer 64 (1995) 27-31
13. Nathan C.A., Liu L., Li B., Nandy I., Abreo F., and De Benedetti A. Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer. Oncogene 15 (1997) 579-584
14. Sonenberg N., and Gingras A.C. The mRNA 5′ cap-binding protein eIF4E and control of cell growth. Curr Open Cell Biol 10 (1998) 268-275
15. Schneider R.J., and Sonenberg N. Translational control in cancer development and progression. In: Mathews M.B., Sonenberg N., and Hershey J.W.B. (Eds). Translational control in biology and medicine (2007), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York 401-431
16. Graff J.R., Boghaert E.R., De Benedetti A., Tudor D.L., Zimmer C.C., Chan S.K., et al. Reduction of translation initiation factor 4E decreases the malignancy of ras-transformed cloned rat embryo fibroblasts. Int J Cancer 60 (1995) 255-263
17. Culjkovic B., Topisirovic I., Skrabanek L., Ruiz-Gutierrez M., and Borden K.L. eIF4E is a central node of an RNA regulon that governs cellular proliferation. J Cell Biol 175 (2006) 415-426
18. Rosenwald I.B., Lazaris-Karatzas A., Sonenberg N., and Schmidt E.V. Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor eIF4E. Mol Cell Biol 13 (1993) 7358-7363
19. Rosenwald I.B., Kaspar R., Rousseau D., Gehrke L., Leboulch P., Chen J.J., et al. Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and posttranscriptional levels. J Biol Chem 270 (1995) 21176-21180
20. Rousseau D., Caspar R., Rosenwald I., Gherkin L., and Sonenberg N. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc Natl Acad Sci USA 93 (1996) 1065-1070
21. Shantz L.M., and Pegg A.E. Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with euplastic transformation. Cancer Res 54 (1994) 2313-2316
22. Shantz L.M., Hu R.H., and Pegg A.E. Regulation of ornithine decarboxylase in a transformed cell line that overexpressed translation initiation factor eIF-4E. Cancer Res 56 (1996) 3265-3269
23. Aoki M., Blazek E., and Vogt P.K. A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt. Proc Natl Acad Sci USA 98 (2001) 136-141
24. Ruggero D., Montana L., Ma L., Xu W., Londei P., Cordon-Cardo C., et al. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nature Med 10 (2004) 484-486
25. Avdulov S., Li S., Michalek V., Burrichter D., Peterson M., Periman D.M., et al. Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell 5 (2004) 553-563
26. Wendel H.-G., de Stanching E., Friedman J.S., Malina A., Ray S., Cogan S., et al. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 428 (2004) 332-337
27. Fukuchi-Shimogori T., Ishii I., Kashiwagi K., Mashiba H., Ekimoto H., and Igarashi K. Malignant transformation by overproduction of translation initiation factor eIF4G malignant transformation by overproduction of translation initiation factor eIF4G. Cancer Res 57 (1997) 5041-5044
28. Koromilas A.E., Roy S., Barber G., Katz M.G., and Sonenberg N. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257 (1992) 1685-1689
29. Meurs E.F., Galabru J., Barber G.N., Katz M.G., and Hovanessian A.G. Tumour suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 90 (1993) 232-236
30. Barber G.N., Wambach M., Thompson S., Jagus R., and Katze M.G. Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation. Mol Cell Biol 15 (1995) 3138-3146
31. Donzé O., Jagus R., Koromilas A.E., Hershey J.W.B., and Sonenberg N. Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J 14 (1995) 3828-3834
32. Brass N., Heckle D., Sahin U., Pfreundschuh M., Sybrecht G.W., and Meese E. Translation initiation factor eIF4gammma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. Human Mol Genet 6 (1997) 33-39
33. Eberle J., Krasagakis K., and Orfanos C.E. Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int J Cancer 71 (1997) 396-401
34. De Benedetti A., and Harris A.L. eIF4E expression in tumors: its possible role in progression of malignancies. Int J Biochem Cell Biol 31 (1999) 59-72
35. Yang H.S., Jansen A.P., Kumar A.A., Zhen X., Merrick W.C., Costes S., et al. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 23 (2003) 26-37
36. Bachmann F., Banziger R., and Burger M.M. Cloning of a novel protein overexpressed in human mammary carcinoma. Cancer Res 57 (1997) 988-994
37. Dellas A., Torhorst J., Bachmann F., Banziger R., Schulthesis E., and Burger M.M. Expresssion of p150 in cervical neoplasia and its potential value in predicting survival. Cancer 83 (1998) 1376-1383
38. Chen G., and Burger M.M. p150 expression and its prognostic value in squamous-cell carcinoma of the esophagus. Int J Cancer 84 (1999) 95-100
39. Nupponen N.N., Pokka K., Akola L., Tanner M., Persson K., Borg A., et al. Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. Am J Patrol 154 (1999) 1777-1783
40. Marchetti A., Battista F., Pellegrini S., Bertacca G., and Callahan R. Reduced expression of INT-6/eIF3-p48 in human tumors. Int J Patrol 18 (2001) 175-179
41. Rothe M., Ko Y., Albers P., and Werner N. Eukaryotic initiation factor 3 p110 mRNA is oveexpressed in testicular seminomas. Am J Patrol 157 (2000) 1597-1664
42. Marchetti A., Battista F., Miyazaki S., Gallahan D., Smith G.H., and Gallahan R. Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia. J Viral 69 (1995) 1932-1938
43. Asano K., Merrick W.C., and Hershey J.W.B. The translation initiation factor eIF3-p48 subunit is encoded by int-6, a site of frequent integration by the mouse mammary tumor virus genome. J Biol Chem 272 (1997) 23477-23480
44. Desbois C., Rousset R., Bantignies F., and Jalinot P. Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-1 Tax oncoprotein. Science 273 (1996) 951-953
45. Morris-Desbois C., Bochard V., Reynaud C., and Jalinot P. Interaction between the Ret finger protein and the int-6 gee product and co-localization into nuclear bodies. J Cell Sci 112 (1999) 3331-3342
46. Zhang L., Pan X., and Hershey J.W.B. Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells. J Biol Chem 282 (2007) 5790-5800
47. Zhang L., Smit-McBride Z., Pan X., Rheinhardt J., and Hershey J.W.B. An oncogenic role for the human translation initiation factor eIF3h. J Biol Chem 283 (2008) 24047-24060
48. Tuerk C., and Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249 (1990) 505-510
49. Ellington A.D., and Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature 346 (1990) 818-822
50. Ellington A.D., and Szostak J.W. Selection in vitro of single stranded DNA molecules that fold into specific ligand-binding structures. Nature 355 (1992) 850-852
51. Oguro A., Otsu T., Svitkin Y.V., Sonenberg N., and Nakamura Y. RNA aptamers to initiation factor 4A helicase hinder cap-dependent translation by blocking ATP hydrolysis. RNA 9 (2003) 394-407
52. Miyakawa S., Oguro A., Otsu T., Imataka H., Sonenberg N., and Nakamura Y. RNA aptamers to mammalian initiation factor 4G inhibit cap-dependent translation by blocking the formation of initiation factor complexes. RNA 12 (2006) 1825-1834
53. Ohuchi S.P., Otsu T., and Nakamura Y. Selection of RNA aptamers against recombinant transforming growth factor-b type III receptor displayed on cell surface. Biochimie 88 (2006) 897-904
54. Klussmann S. The aptamer handbook (2006), WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
55. Keefe A.D., and Schaub R.G. Aptamers as candidate therapeutics for cardiovascular indications. Curr Open Pharmacol 8 (2008) 1-6
56. Romig T.S., Bell C., and Droplet D.W. Aptamer affinity chromatography: combinatorial chemistry applied to protein purification. J Chromatogr B Biomed Sci Appl 731 (1999) 275-284
57. Blank M., Weinschenk T., Priemer M., and Schluesener H. Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. Selective targeting of endothelial regulatory protein pigpen. J Biol Chem 276 (2001) 16464-16468
58. Ng E.W., Shim D.T., Calais P., Cunningham Jr. E.T., Gayer D.R., and Adams A.P. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Dis 5 (2006) 123-132
59. Zhou B., and Wang B. Pegaptanib for the treatment of age-related macular degeneration. Exp Eye Res 83 (2006) 615-619
60. Gesteland R.F., Cech T.R., and Atkins J.F. The RNA world (1999), Cold Spring Harbor Laboratory Press, New York
61. Nakamura Y. Molecular mimicry between protein and tRNA. J Mol Evol 53 (2001) 282-289
62. Venema J., and Tollervey D. Processing of pre-ribosomal RNA in Saccharomyces cerevisiae. Yeast 11 (1995) 1629-1650
63. Py B., Higgins C.F., Krisch H.M., and Carpousis A.J. A DEAD-box RNA helicase in the Escherichia coli RNA degradosome. Nature 381 (1996) 169-172
64. Staley J.P., and Guthrie C. Mechanical devices of the spliceosome: motors, clocks, springs, and things. Cell 92 (1998) 315-326
65. Cordin O., Banroques J., Tanner N.K., and Linder P. The DEAD-box protein family of RNA helicases. Gene 367 (2006) 17-37
66. Pause A., and Sonenberg N. Mutational analysis of a DEAD box RNA helicase: the mammalian translation initiation factor eIF-4A. EMBO J 11 (1992) 2643-2654
67. Pause A., and Sonenberg N. Helicases and RNA unwinding in translation. Curr Open Struct Biol 3 (1993) 953-959
68. Pause A., Méthot N., and Sonenberg N. The HRIGRXXR region of the DEAD box RNA helicase eukaryotic translation initiation factor 4A is required for RNA binding and ATP hydrolysis. Mol Cell Biol 13 (1993) 6789-6798
69. Lüking A., Stahl U., and Schmidt U. The protein family of RNA helicases. Crit Rev Biochem Mol Biol 33 (1998) 259-296
70. Tanner N.K., Cordin O., Banroques J., Doère M., and Linder P. The Q motif: a newly identified motif in DEAD box helicases may regulate ATP binding and hydrolysis. Mol Cell 11 (2003) 127-138
71. Cordin O., Tanner N.K., Doère M., Linder P., and Banroques J. The newly discovered Q motif of DEAD-box RNA helicases regulates RNA-binding and helicase activity. EMBO J 23 (2004) 2478-2487
72. Svitkin Y.V., Pause A., Haghighat A., Pyronnet S., Witherell G., Belsham G.J., et al. The requirement for eukaryotic initiation factor 4A (eIF4A) in translation is in direct proportion to the degree of mRNA 5′ secondary structure. RNA 7 (2001) 382-394
73. Tanner N.K., and Linder P. Dead/H box RNA helicases: from generic motors to specific dissociation functions. Mol Cell 8 (2001) 251-262
74. Benz J., Trachsel H., and Baumann U. Crystal structure of ATPase domain of translation initiation factor eIF4A from Saccharomyces cerevisiae-the prototype of the DEAD box protein family. Struct Fold Des 7 (1999) 671-679
75. Johnson E.R., and McKay D.B. Crystallographic structure of the amino terminal domain of yeast initiation factor 4A, a representative DEAD-box RNA helicase. RNA 5 (1999) 1526-1534
76. Caruthers J.M., Johnson E.R., and McKay D.B. Crystal structure of yeast initiation factor 4A, a DEAD-box RNA helicase. Proc Natl Acad Sci USA 97 (2000) 3080-3085
77. Schütz P., Bumann M., Oberholzer A.E., Bieniossek C., Trachsel H., Altmann M., et al. Crystal structure of the yeast eIF4A-eIF4G complex: an RNA-helicase controlled by protein-protein interactions. Proc Natl Acad Sci USA 105 (2008) 9564-9569
78. Chang J.H., Cho Y.H., Sohn S.Y., Choi J.M., Kim A., Kim Y.C., et al. Crystal structure of the eIF4A-PDCD4 complex. Proc Natl Acad Sci USA 106 (2009) 3148-3153
79. Abramson R.D., Dever T.E., Lawson T.G., Ray B.K., Thach R.E., and Merrick W.C. The ATP-dependent interaction of eukaryotic initiation factors with mRNA. J Biol Chem 262 (1987) 3826-3832
80. Abramson R.D., Dever T.E., and Merrick W.C. Biochemical evidence supporting a mechanism for cap-independent and internal initiation of eukaryotic mRNA. J Biol Chem 263 (1988) 6016-6019
81. Lorsch J.R., and Herschlag D. The DEAD box protein eIF4A. 1. A minimal kinetic and thermodynamic framework reveals coupled binding of RNA and nucleotide. Biochemistry 37 (1998) 2180-2193
82. Mattaji I.W. RNA recognition: a family matter?. Cell 73 (1993) 837-840
83. Kim J.L., Morgenstern K.A., Griffith J.P., Dwyer M.D., Thomson J.A., Murcko M.A., et al. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Structure 6 (1998) 89-100
84. Lorsch J.R., and Herschlag D. The DEAD box protein eIF4A. 2. A cycle of nucleotide and RNA-dependent conformational changes. Biochemistry 37 (1998) 2194-2206
85. Sakamoto T., Oguro A., Kawai G., Sonenberg N., Otsu T., and Nakamura Y. NMR structures of double loops of an RNA aptamer against mammalian initiation factor 4A. Nucl Acids Res 33 (2005) 745-754
86. Valencia-Burton M., McCullough R.M., Cantor C.R., and Broude N.E. RNA visualization in live bacterial cells using fluorescent protein complementation. Nat Methods 4 (2007) 421-427
87. Oguro A., Otsu T., and Nakamura Y. Aptamer-based biosensor for mammalian initiation factor eIF4A. Anal Biochem 388 (2009) 102-107
88. Ferraiuolo M.A., Lee C.S., Ler L.W., Hsu J.L., Costa-Mattioli M., Luo M.J., et al. A nuclear translation-like factor eIF4AIII is recruited to the mRNA during splicing and functions in nonsense-mediated decay. Proc Natl Acad Sci USA 101 (2004) 4118-4123
89. Palacios I.M., Gatfield D., St Johnston D., and Izaurralde E. An eIF4AIII-containing complex required for mRNA localization and nonsense-mediated mRNA decay. Nature 427 (2004) 753-757
90. Shibuya T., Tange T.O., Sonenberg N., and Moore M.J. eIF4AIII binds spliced mRNA in the exon junction complex and is essential for nonsense-mediated decay. Nat Struct Mol Biol 11 (2004) 346-351
91. Le Hir H., Moore M.J., and Maquat L.E. Pre-mRNA splicing alters mRNP composition: evidence for stable association of proteins at exon-exon junctions. Genes Dev 14 (2000) 1098-1108
92. Shatkin A. Capping of eukaryotic mRNAs. Cell 9 (1976) 645-653
93. Duncan R., Milburn S.C., and Hershey J.W.B. Regulated phosphorylation and low abundance of HeLa cell initiation factor 4F suggest a role in translational control. J Biol Chem 262 (1987) 380-388
94. Flynn A., and Proud C.G. Ser209, but not Ser53, is the major site of phosphorylation in initiation factor eIF4E in serum treated Chinese hamster ovary cells. J Biol Chem 270 (1995) 21684-21688
95. Joshi B., Cai A.L., Keeper B.D., Munich W.B., Mendez R., Beach C.M., et al. Phosphorylation of eukaryotic protein synthesis initiation factor 4E at Ser209. J Biol Chem 270 (1995) 14597-14603
96. Fukunaga R., and Hunter T. Mnk1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J 16 (1997) 1921-1933
97. Waskiewicz A.J., Flynn A., Proud C.G., and Cooper J.A. Mitogen-activated protein kinase activate the serine/threonine kinase Mnk1 and Mnk2. EMBO J 16 (1997) 1909-1920
98. Scheper G.C., van Kollenburg B., Hu J., Luo Y., Goss D.J., and Proud C.G. Phosphorylation of eukaryotic initiation factor 4E markedly reduces its affinity for capped mRNA. J Biol Chem 277 (2002) 3303-3309
99. Zuberek J., Wyslouch-Cieszynska A., Niedzwiecka A., Addles M., Stepinski J., Augustyniak W., et al. Phosphorylation of eIF4E attenuates its interaction with mRNA 5′ cap analogs by electrostatic repulsion: intern-mediated protein ligation strategy to obtain phosphorylated protein. RNA 9 (2003) 52-61
100. Gingras A.-C., Raught B., Gygi S.P., Niedzwiecka A., Miron M., Burley S.K., et al. Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev 15 (2001) 2852-2864
101. Haghighat A., Mader S., Pause A., and Sonenberg N. Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E. EMBO J 14 (1995) 5701-5709
102. Mader S., Lee J., Pause A., and Sonenberg N. The translation initiation factor eIF4E binds to a common motif shared by the translation factor eIF-4G and the translational repressors, 4E-binding proteins. Mol Cell Biol 15 (1995) 4990-4997
103. Marcotrigiano J., Gingras A.C., Sonenberg N., and Burley S.K. Cap-dependent translation initiation in eukaryotes is regulated by a molecular mimic of eIF4G. Mol Cell 3 (1999) 707-716
104. Mochizuki K., Oguro A., Otsu T., Sonenberg N., and Nakamura Y. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation. RNA 11 (2005) 77-89
105. Marcotrigiano J., Gingras A.C., Sonenberg N., and Burley S.K. Cocrystal structure of the messenger RNA 5′ cap-binding protein (eIF4E) bound to 7-methyl-GDP. Cell 89 (1997) 951-961
106. Tomoo K., Shen X., Okabe K., Nozoe Y., Fukunaga S., Morino S., et al. Structural features of human initiation factor 4E, studied by X-ray crystal analyses and molecular dynamics simulations. J Mol Biol 328 (2003) 365-383
107. Altmann M., Muller P.P., Pelletier J., Sonenberg N., and Trachsel H. A mammalian translation initiation factor can substitute for its yeast homologue in vivo. J Biol Chem 264 (1989) 12145-12147
108. Prevot D., Darlix J.-L., and Holman T. Conducting the initiation of protein synthesis: the role of eIF4G. Biol Cell 95 (2003) 141-156
109. He H., van der Haar T., Singh C.R., Ii M., Li B., Hinnebusch A.G., et al. The yeast eukaryotic initiation factor 4G (eIF4G) HEAT domain interacts with eIF1 and eIF5 and is involved in stringent AUG selection. Mol Cell Biol 23 (2003) 5431-5445
110. Pyronnet S., Imataka H., Gingras A.-C., Fukunaga R., Hunter T., and Sonenberg N. Human eukaryotic translation initiation factor 4G (eIF4G) recruits Mnk1 to phosphorylate eIF4E. EMBO J 18 (1999) 270-279
111. Wells S.E., Hillier P.E., Vale R.D., and Sachs A.B. Circularization of mRNA by eukaryotic translation initiation factors. Mol Cell 2 (1998) 135-140
112. Tarun Jr. S.Z., and Sachs A.B. Association of the yeast poly(A) tail binding protein with translation initiation factor eIF-4G. EMBO J 15 (1996) 7168-7177
113. Uchida N., Hoshino S., Imataka H., Sonenberg N., and Katada T. A novel role of the mammalian GSPT/eRF3 associating with poly(A)-binding protein in cap/poly(A)-dependent translation. J Biol Chem 277 (2002) 50286-50292
114. Lejeune F., Ranganathan A.C., and Maquat L.E. eIF4G is required for the pioneer round of translation in mammalian cells. Nat Struct Mol Biol 11 (2004) 992-1000
115. Korneeva N.L., Lamphear B.J., Shenanigan F.L.C., and Rhoads R.E. Mutually cooperative binding of eukaryotic translation initiation factor (eIFs) 3 and eIF4A to human eIF4G-1. J Biol Chem 275 (2000) 41369-41376
116. Imataka H., and Sonenberg N. Human eukaryotic translation initiation factor 4G (eIF4G) possesses two separate and independent binding sites for eIF4A. Mol Cell Biol 17 (1997) 6940-6947
117. Morino S., Imataka H., Svitkin Y.V., Pestova T.V., and Sonenberg N. Eukaryotic translation initiation factor 4E (eIF4E) binding site and the middle one-third of eIF4GI constitute the core domain for cap-dependent translation, and the C-terminal one-third functions as a modulatory region. Mol Cell Biol 20 (2000) 468-477
118. Lomakin I.B., Hellen C.U.T., and Pestova T.V. Physical association of eukaryotic initiation factor 4G (eIF4G) with eIF4A strongly enhances binding of eIF4G to the internal ribosomal entry site of encephalomyocarditis virus and is required for internal initiation of translation. Mol Cell Biol 20 (2000) 6019-6029
119. Marcotrigiano J., Lomakin I.B., Sonenberg N., Pestova T.V., Hellen C.U.T., and Burley S.K. A conserved HEAT domain within eIF4G directs assembly of the translation initiation machinery. Mol Cell 7 (2001) 193-203
120. Battiste J.L., Pestova T.V., Hellen C.U., and Wagner G. The eIF1A solution structure reveals a large RNA-binding surface important for scanning function. Mol Cell 5 (2000) 109-119
121. Méthot N., Pause A., Hershey J.W.B., and Sonenberg N. The translation initiation factor eIF-4B contains an RNA binding region that is distinct and independent from its ribonucleoprotein consensus sequence. Mol Cell Biol 14 (1994) 2307-2316
122. Méthot N., Pickett G., Keene J.D., and Sonenberg N. In vitro RNA selection identifies RNA ligands that specifically bind to eukaryotic translation initiation factor 4B: the role of the RNA recognition motif. RNA 2 (1996) 38-50
123. +], and ribosome recycling. In: Mathews M.B., Sonenberg N., and Hershey J.W.B. (Eds). Translational control in biology and medicine (2007), Cold Spring Harbor Laboratory Press, New York, NY 173-196
124. Kisselev L., Ehrenberg M., and Frolova L. Termination of translation: interplay of mRNA, rRNA and release factors?. EMBO J 22 (2003) 175-182
125. Nakamura Y., and Ito K. Making sense of mimic in translation termination. Trends Biochem Sci 28 (2003) 99-105
126. Nakamura Y., Ito K., and Ehrenberg M. Mimicry grasps reality in translation termination. Cell 101 (2000) 349-352
127. Frolova L., Le Goff X., Rasmussen H.H., Cheperegin S., Drugeon G., Kress M., et al. A highly conserved eukaryotic protein family possessing properties of polypeptide chain release factor. Nature 372 (1994) 701-703
128. Stansfield I., Jones K.M., Kushnirov V.V., Dagkesamanskaya A.R., Poznyakovski A.I., Paushkin S.V., et al. The product of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J 14 (1995) 4365-4373
129. Zhouravleva G., Frolova L., Le Goff X., Le Guellec R., Inge-Vechtomov S., Kisselev L., et al. Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. EMBO J 14 (1995) 4065-4072
130. Carnes J., Frolova L.A., Zinnen S., Drugeon G., Phillippe M., Justesen J., et al. Suppression of eukaryotic translation termination by selected RNAs. RNA 6 (2000) 1468-1470
131. Winkler W.C., and Breaker R.R. Genetic control by metabolite-binding riboswitches. ChemBioChem 4 (2003) 1024-1032
132. Badis G., Saveanu C., Fromount-Racine M., and Jacquier A. Targeted mRNA degradation by deadenylation-independent decapping. Mol Cell 15 (2004) 5-15
133. Nudler E., and Mironov A.S. The riboswitch control of bacterial metabolism. Trends Biochem Sci 29 (2004) 11-17
134. Montange R.K., and Batey R.T. Structure of the S-adenosylmethionine riboswitch regulatory mRNA element. Nature 441 (2006) 1172-1175
135. Stoddard C.D., Gibert S.D., and Batey R.T. Ligand-dependent folding of the three-way junction in the purine riboswitch. RNA 14 (2008) 675-684
136. Ohuchi S.P., Ikawa Y., and Nakamura Y. Selection of a novel class of RNA-RNA interaction motifs based on the ligase ribozyme with defined modular architecture. Nucl Acids Res 36 (2008) 3600-3607
137. Lescoute A., Leontis N.B., Messier C., and Weston E. Recurrent structural RNA motifs, isostericity matrices and sequence alignments. Nucleic Acids Res 33 (2005) 2395-2409
138. Hinton T.M., Coldwell M.J., Carpenter G.A., Morley S.J., and Pain V.M. Functional analysis of individual binding activities of the scaffold protein eIF4G. J Biol Chem 282 (2007) 1695-1708
139. Svitkin Y.V., Herdy B., Costa-Mattioli M., Gingras A.C., Raught B., and Sonenberg N. Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation. Mol Cell Biol 25 (2005) 10556-10565
140. Del Bufalo D., Ciuffreda L., Trisciuoglio D., Desideri M., Cognetti F., Zupi G., et al. Antiangiogenic potential of the mammalian target of rapamycin inhibitor temsirolimus. Cancer Res 66 (2006) 5549-5554
141. Barnhart B.C., Lam J.C., Young R.M., Houghton P.J., Keith B., and Simon M.C. Effects of 4E-BP1 expression on hypoxic cell cycle inhibition and tumor cell proliferation and survival. Cancer Biol Ther 7 (2008) 1441-1449
142. Dong K., Wang R., Wang X., Lin F., Shen J.J., Gao P., et al. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells. Breast Cancer Res Treat 113 (2009) 443-456
143. De Benedetti A., and Graff J.R. eIF4E expression and its role in malignancies and metastases. Oncogene 23 (2004) 3189-3199
144. Graff J.R., Konicek B.W., Carter J.H., and Marcusson E.G. Targeting the eukaryotic translation initiation factor 4E for cancer therapy. Cancer Res 68 (2008) 631-634
145. Graff J.R., Konicek B.W., Vincent T.M., Lynch R.L., Monteith D., et al. Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. J Clin Invest 117 (2007) 2638-2648
146. Ko S.Y., Guo H., Barengo N., and Nora H. Inhibition of ovarian cancer growth by a tumor-targeting peptide that binds eukaryotic translation initiation factor 4E. Clin Cancer Res 15 (2009) 4336-4347
147. Clemens M.J. Targets and mechanisms for the regulation of translation in malignant transformation. Oncogene 23 (2004) 3180-3188
148. Fletcher C.M., and Wagner G. The interaction of eIF4E with 4E-BP1 is an induced fit to a completely disordered protein. Protein Sci 7 (1998) 1639-1642
149. Ito K., Uno M., and Nakamura Y. A tripeptide "anticodon" deciphers stop codons in messenger RNA. Nature 403 (2000) 680-684
150. Wang H., Iacoangeli A., Popp S., Muslimov I.A., Imataka H., Sonenberg N., et al. Dendritic BC1 RNA: functional role in regulation of translation initiation. J Neurosci 22 (2002) 10232-10241
151. Chicurel M.E., Terrian D.M., and Potter H. mRNA at the synapse: analysis of a synaptosomal preparation enriched in hippocampal dendritic spines. J Neurosci 13 (1993) 4054-4063
152. Lin D., Pestova T.V., Hellen C.U., and Tiedge H. Translational control by a small RNA: dendritic BC1 RNA targets the eukaryotic initiation factor 4A helicase mechanism. Mol Cell Biol 28 (2008) 3008-3019
153. Shamovsky I., Ivannikov M., Kindle E.S., Gershon D., and Nudler E. RNA-mediated response to heat shock in mammalian cells. Nature 440 (2006) 556-560
154. Niedzwiecka A., Marcotrigiano J., Stepinski J., Jankowska-Anyszka M., Wyslouch-Cieszynska A., Dadlez M., et al. Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5′ cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins. J Mol Biol 319 (2002) 615-635